BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
57 auth. S. Al-Batran, N. Homann, C. Pauligk, T. Goetze, J. Meiler, S. Kasper, H. Kopp, F. Mayer, G. Haag, K. Luley, U. Lindig, W. Schmiegel, M. Pohl, J. Stoehlmacher, G. Folprecht, ... S. Probst, N. Prasnikar, W. Fischbach, R. Mahlberg, J. Trojan, M. Koenigsmann, U. Martens, P. Thuss-Patience, M. Egger, A. Block, V. Heinemann, G. Illerhaus, M. Moehler, M. Schenk, F. Kullmann, D. Behringer, M. Heike, D. Pink, C. Teschendorf, Carmen Löhr, H. Bernhard, G. Schuch, V. Rethwisch, L. F. V. Weikersthal, J. Hartmann, M. Kneba, S. Daum, K. Schulmann, J. Weniger, S. Belle, T. Gaiser, F. Oduncu, M. Güntner, W. Hozaeel, Alexander Reichart, E. Jäger, T. Kraus, S. Mönig, W. Bechstein, M. Schuler, H. Schmalenberg, R. Hofheinz
10 2019
10
🐜
🐜 Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multice
40 auth. S. Al-Batran, R. Hofheinz, C. Pauligk, H. Kopp, G. Haag, K. Luley, J. Meiler, N. Homann, S. Lorenzen, H. Schmalenberg, S. Probst, M. Koenigsmann, M. Egger, N. Prasnikar, K. Caca, ... J. Trojan, U. Martens, A. Block, W. Fischbach, R. Mahlberg, M. Clemens, G. Illerhaus, K. Zirlik, D. Behringer, W. Schmiegel, M. Pohl, M. Heike, U. Ronellenfitsch, M. Schuler, W. Bechstein, A. Königsrainer, T. Gaiser, P. Schirmacher, W. Hozaeel, Alexander Reichart, T. Goetze, M. Sievert, E. Jäger, S. Mönig, A. Tannapfel
9 2016
9
🐜
🦁 Adenoviral‐Mediated Herpes Simplex Virus Thymidine Kinase Gene Transfer: Regression of Hepatic Metastasis of Pancreatic Tumors
A. Block, Shu-Hsia Chen, K. Kosai, M. Finegold, S. Woo
5 1997
5
🦁
🐬 Characterization of Effusion-Infiltrating T Cells
D. Atanackovic, A. Block, A. de Weerth, C. Faltz, D. Hossfeld, S. Hegewisch‐Becker
5 2004
5
🐬
🐜 PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.
23 auth. A. Vogel, S. Kasper, M. Bitzer, A. Block, M. Sinn, H. Schulze‐Bergkamen, M. Moehler, N. Pfarr, V. Endris, B. Goeppert, ... K. Merx, E. Schnoy, J. Siveke, P. Michl, D. Waldschmidt, J. Kuhlmann, M. Geissler, C. Kahl, Ralph Evenkamp, T. Schmidt, A. Kuhlmann, W. Weichert, S. Kubicka
5 2018
5
🐜
🐜 Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
10 auth. M. Sutton, S. Berkman, S. Chen, A. Block, T. Dang, M. Kattan, ... T. Wheeler, D. Rowley, S. Woo, S. Lerner
5 1997
5
🐜
🐜 In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration.
9 auth. X. Tong, A. Block, S. Chen, C. Contant, I. Agoulnik, K. Blankenburg, ... R. Kaufman, S. Woo, D. Kieback
5 1996
5
🐜
🐜 Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg
8 auth. K. Weisel, A. Morgner-Miehlke, C. Petersen, W. Fiedler, A. Block, P. Schafhausen, ... J. Knobloch, C. Bokemeyer
5 2020
5
🐜
🐬 Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir.
X. Tong, A. Block, S. Chen, S. Woo, D. Kieback
4 1996
4
🐬
🐜 Esophageal squamous cell carcinoma presenting with extensive skin lesions: a case report
7 auth. G. Iwański, A. Block, G. Keller, J. Muench, S. Claus, W. Fiedler, ... C. Bokemeyer
4 2008
4
🐜
🐜 Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model.
8 auth. B. Bonnekoh, D. Greenhalgh, S. Chen, A. Block, S. Rich, T. Krieg, ... S. Woo, D. Roop
4 1998
4
🐜